Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Routes for Postoperative Delirium
NCT05952050Unknown
- Start
- Aug 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in postoperative delirium (POD) (2 arms). Primary endpoint: Frequency of delirium at 3 days. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT05952050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05952050.